ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2023

Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis).

Alessandra Narcisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.